Page last updated: 2024-12-04

12,20-dihydroxy-5,8,10,14-eicosatetraenoic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

12,20-dihydroxy-5,8,10,14-eicosatetraenoic acid (12,20-DiHETE) is a **specialized pro-resolving mediator (SPM)** derived from the metabolism of **arachidonic acid**.

Here's a breakdown of its key features and importance in research:

**1. Chemical Structure and Formation:**

* **Structure:** It is a 20-carbon fatty acid with four double bonds and hydroxyl groups at the 12th and 20th carbon positions.
* **Formation:** 12,20-DiHETE is formed through the enzymatic action of 12/20-lipoxygenases (LOXs) on arachidonic acid. These enzymes are found in various cells, including immune cells.

**2. Biological Activities:**

* **Anti-inflammatory:** 12,20-DiHETE exhibits potent anti-inflammatory properties by inhibiting the production of pro-inflammatory cytokines, such as TNF-α and IL-6.
* **Pro-resolution:** It plays a crucial role in resolving inflammation by promoting the clearance of neutrophils and other inflammatory cells, and stimulating tissue repair.
* **Immunomodulatory:** 12,20-DiHETE modulates immune responses by influencing the differentiation and activation of immune cells.
* **Other Potential Activities:** 12,20-DiHETE may have additional roles in cell signaling, angiogenesis (new blood vessel formation), and wound healing.

**3. Research Significance:**

* **Understanding Inflammation:** 12,20-DiHETE provides valuable insights into the complex mechanisms of inflammation resolution, contributing to our understanding of how the body naturally controls and resolves inflammation.
* **Therapeutic Potential:** 12,20-DiHETE is being investigated as a potential therapeutic agent for various inflammatory conditions, such as inflammatory bowel disease, arthritis, and sepsis. It may also have potential applications in wound healing and tissue regeneration.
* **Novel Drug Targets:** The pathways involved in 12,20-DiHETE production and signaling are being explored as potential targets for developing novel anti-inflammatory drugs.

**4. Ongoing Research:**

* Research continues to investigate the exact mechanisms of action, optimal dosing, and potential side effects of 12,20-DiHETE.
* Scientists are also exploring the use of 12,20-DiHETE analogs and synthetic derivatives with improved stability and efficacy.

**In summary, 12,20-DiHETE is a promising bioactive molecule with significant therapeutic potential. Research on 12,20-DiHETE holds the key to developing novel treatments for a wide range of inflammatory diseases and promoting tissue repair and regeneration.**

Cross-References

ID SourceID
PubMed CID1412
MeSH IDM0121137

Synonyms (2)

Synonym
12,20-dihydroxyicosa-5,8,10,14-tetraenoic acid
12,20-dihydroxy-5,8,10,14-eicosatetraenoic acid
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (66.67)18.7374
1990's2 (33.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.41

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.41 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.36 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.41)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (16.67%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (83.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]